Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Drug of Abuse Testing Services Market Size & Growth Forecast 2027–2036, By Segments (Drug), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 3997| Published Date: Aug-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Drug of Abuse Testing Services Market size was more than USD 4.5 billion in 2026 and is set to grow at a 5.23% CAGR between 2027 and 2036, exceeding USD 7.49 billion by 2036. The industry revenue for 2027 is calculated at USD 4.7 billion.

Base Year Value (2026)
USD 4.5 billion
CAGR (2027-2036)
5.23%
Forecast Year Value (2036)
USD 7.49 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
SNAPSHOT

Drug of Abuse Testing Services Market Intelligence Snapshot

Regional Market Dynamics

  • North America holds 53.66% share due to established testing infrastructure, widespread workplace screening programs, and strong demand from healthcare, justice, and regulated industries.
  • Asia Pacific growth at 5.7% CAGR is driven by expanding workplace screening adoption, rising substance monitoring awareness, and improving access to structured testing services.

Segment Momentum

  • Cannabis/Marijuana led the market with a 60.17% share in 2026, supported by its frequent inclusion in workplace screening programs, compliance testing panels, and routine toxicology workflows.
  • Cannabis/Marijuana continues to grow fastest because testing demand remains consistently high, with service providers seeing strong utilization as it remains a core component of standard screening menus.

Market Expansion Drivers

  • Rising prevalence of substance use disorders increasing demand for workplace and clinical drug testing.
  • Growing marijuana and opioid consumption accelerating adoption of comprehensive screening programs.
  • Expanding public awareness campaigns improving access to addiction prevention and testing services.

Leading Market Participants

  • Key companies in the drug of abuse testing services market include Quest Diagnostics Incorporated (United States), Abbott Laboratories (United States), Laboratory Corporation of America Holdings (United States), Clinical Reference Laboratory, Inc. (United States), Cordant Health Solutions (United States), Legacy Medical Services (United States), DrugScan, Inc. (United States), Omega Laboratories, Inc. (United States), Psychemedics Corporation (United States), Millennium Health, LLC (United States).

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 4.5 billion
  • 2027 Estimated Market Size: USD 4.7 billion.
  • Projected Market Size: USD 7.49 billion by 2036
  • Growth Forecast: 5.23% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Cannabis/Marijuana (Drug)
  • Emerging Opportunity Segment: Cannabis/Marijuana (Drug)
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising prevalence of substance use disorders increasing demand for workplace and clinical drug testing

The growing prevalence of substance use disorders will drive the drug of abuse testing services market as employers, healthcare providers, and other institutions seek reliable methods for identifying substance exposure and supporting appropriate interventions. In workplace environments, testing programs can form part of broader occupational safety and risk-management practices, while clinical settings use testing to assist with patient assessment, treatment monitoring, and addiction management. Increasing recognition of substance misuse as a significant public health and workplace concern is therefore expanding the need for accessible testing services across different screening environments.

Growing marijuana and opioid consumption accelerating adoption of comprehensive screening programs

Growing consumption of marijuana and opioids is encouraging broader screening practices and will propel the drug of abuse testing services market by increasing demand for testing panels capable of identifying multiple substances. Healthcare and workplace programs are increasingly focused on comprehensive screening rather than isolated substance detection, particularly where changing patterns of substance use create more complex testing requirements. The need to detect relevant substances efficiently is also supporting the adoption of laboratory-based and other testing approaches that can be incorporated into routine clinical assessments, employment-related programs, and substance misuse monitoring.

Expanding public awareness campaigns improving access to addiction prevention and testing services

Public awareness campaigns focused on addiction prevention are expanding understanding of substance misuse and encouraging individuals to seek screening, counseling, and related support services, thereby strengthening the drug of abuse testing services market. Greater awareness can reduce barriers to testing by helping communities recognize the value of early identification and encouraging healthcare professionals and organizations to incorporate screening into broader prevention initiatives. As prevention efforts reach more workplaces, healthcare settings, and community programs, testing services can become more closely integrated with educational and intervention activities designed to identify substance-use concerns at an earlier stage.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising prevalence of substance use disorders increasing demand for workplace and clinical drug testing 1.80% High North America, Asia Pacific High Near Term
Growing marijuana and opioid consumption accelerating adoption of comprehensive screening programs 1.60% High North America, Europe High Mid Term
Expanding public awareness campaigns improving access to addiction prevention and testing services 1.30% Moderate Asia Pacific, North America Medium Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
53.66% Market Share in 2026

North America (Largest Region)

The drug of abuse testing services market was dominated by North America, which accounted for a 53.66% share in 2026, reflecting established testing infrastructure, strong demand for substance screening, and broad implementation across healthcare, workplace, criminal justice, and other institutional settings. The region benefits from mature laboratory networks, established testing protocols, and continued attention to substance misuse and public safety. Growing demand for reliable screening, advancements in testing methodologies, and the integration of testing services into broader healthcare and monitoring programs are supporting sustained market activity.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is expected to experience the fastest growth as healthcare systems expand their laboratory capabilities and awareness of substance abuse screening increases. Rising urbanization, evolving workplace safety requirements, and greater emphasis on preventive healthcare are encouraging organizations and healthcare providers to adopt more structured testing programs. Improvements in laboratory infrastructure, wider availability of specialized diagnostic services, and increasing efforts to strengthen substance monitoring and public health responses are also creating favorable conditions for the expansion of drug of abuse testing services across the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Regulatory Testing Standards

Germany emphasizes laboratory quality, analytical accuracy, and regulatory compliance across drug of abuse testing services. German testing providers increasingly support occupational health, rehabilitation programs, and clinical toxicology with validated testing methodologies.

France 🇫🇷

Public Health Screening

France supports drug of abuse testing services through healthcare, occupational medicine, and public health initiatives. French laboratories continue improving analytical performance while expanding access to standardized toxicology testing across multiple care settings.

Italy 🇮🇹

Laboratory Service Optimization

Italy is enhancing drug of abuse testing services through laboratory modernization and improved turnaround times. Italian diagnostic providers focus on delivering reliable toxicology testing that supports healthcare institutions, rehabilitation centers, and occupational screening programs.

Japan 🇯🇵

Clinical Toxicology Support

Japan focuses on reliable laboratory-based drug screening within healthcare and clinical toxicology settings. Japanese service providers continue refining testing efficiency and confirmatory analysis while maintaining stringent quality assurance practices.

South Korea 🇰🇷

Rapid Testing Expansion

South Korea is increasing the use of rapid screening services supported by centralized laboratory confirmation for healthcare and workplace applications. South Korean providers are strengthening testing efficiency through automation and digital laboratory management systems.

United States 🇺🇸

Comprehensive Screening Programs

The U.S. drug of abuse testing services market is supported by broad workplace, clinical, and forensic testing requirements. Service providers in the U.S. continue expanding rapid testing capabilities and laboratory confirmation services while improving compliance with evolving testing standards.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Drug of Abuse Testing Services Market Share (%), by Drug, 2026

Cannabis/Marijuana
Opioids
Amphetamine & Methamphetamine
Cocaine
Alcohol
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Drug Segment Analysis: Cannabis/Marijuana (Largest & Fastest-Growing Segment)

Cannabis/Marijuana held the largest share of the drug of abuse testing services market in 2026 while also representing the fastest-growing drug segment, driven by increasing attention to cannabis-related substance use and the need for reliable detection across workplace, clinical, forensic, and other testing environments. Evolving patterns of cannabis consumption and greater awareness of impairment and substance-related risks are supporting demand for screening and confirmatory testing. At the same time, changing legal and social attitudes toward cannabis are increasing the importance of standardized testing programs capable of identifying cannabis exposure accurately, supporting continued demand for specialized drug testing services.

Segment Sub-Segment Largest Segment Fastest Growing
Drug Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, Others Cannabis/Marijuana Cannabis/Marijuana
Competitive Landscape

Competitive Landscape and Market Positioning

Key companies in the drug of abuse testing services market:

1. Quest Diagnostics Incorporated (United States)

2. Abbott Laboratories (United States)

3. Laboratory Corporation of America Holdings (United States)

4. Clinical Reference Laboratory Inc. (United States)

5. Cordant Health Solutions (United States)

6. Legacy Medical Services (United States)

7. DrugScan Inc. (United States)

8. Omega Laboratories Inc. (United States)

9. Psychemedics Corporation (United States)

10. Millennium Health LLC (United States)

Rising demand for rapid and accurate screening solutions is driving innovation in the drug of abuse testing services market. Providers are increasingly adopting automated testing technologies and streamlined laboratory workflows to improve processing efficiency and reduce reporting times. The market is also seeing greater emphasis on portable and point-of-care testing solutions that support expanding workplace, forensic, and healthcare testing requirements.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Quest Diagnostics Incorporated (United States)
Abbott Laboratories (United States)
Laboratory Corporation of America Holdings (United States)
Clinical Reference Laboratory Inc. (United States)
Cordant Health Solutions (United States)
Legacy Medical Services (United States)
DrugScan Inc. (United States)
Omega Laboratories Inc. (United States)
Psychemedics Corporation (United States)
Millennium Health LLC (United States).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Drug of Abuse Testing Services Market — Custom Segments

Segment Sub-Segment
Sample Type Urine, Blood, Saliva, Hair, Breath
Testing Purpose Workplace Testing, Clinical Testing, Forensic Testing, Criminal Justice Testing, Sports & Performance Testing
Test Method Immunoassay, Chromatography-Based Testing, Mass Spectrometry, Other Confirmatory Methods

Drug of Abuse Testing Services Market — Custom

Custom Chapter Custom Details
Workplace Drug Screening Program Benchmarking
  • Employer Screening Program Models and Testing Practices
  • Testing Frequency, Panel Selection, and Workforce Risk Considerations
  • Adoption of Laboratory and Point-of-Care Screening Approaches
  • Program Management and Operational Benchmarking Across Employer Segments
Substance Abuse Policy and Compliance Landscape
  • Workplace Substance-Use Policies and Testing Requirements
  • Regulatory and Compliance Considerations Across Testing Programs
  • Policy Evolution and Implications for Employer Screening Practices
  • Documentation, Governance, and Program Administration Priorities
Criminal Justice and Correctional Testing Demand Assessment
  • Testing Requirements Across Criminal Justice and Correctional Settings
  • Screening Priorities Across Pretrial, Probation, and Correctional Programs
  • Operational Requirements for High-Volume Testing Environments
  • Point-of-Care and Laboratory Testing Deployment Models
  • Demand Drivers Across Public-Sector Testing Programs

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

What is the market valuation of drug of abuse testing services?

The market size of drug of abuse testing services in 2027 is calculated to be USD 4.7 billion.

How much is the drug of abuse testing services industry expected to grow by 2036?

Drug of Abuse Testing Services Market size was more than USD 4.5 billion in 2026 and is set to grow at a 5.23% CAGR between 2027 and 2036, exceeding USD 7.49 billion by 2036.

How are evolving substance use patterns influencing purchasing decisions in the drug of abuse testing services market?

Organizations increasingly favor comprehensive screening programs with confirmatory testing and integrated interpretation services to address multiple substance classes, prescription misuse, and changing compliance and clinical requirements.

Why is repeat testing becoming a significant growth driver in the drug of abuse testing services market?

Workplace safety initiatives and ongoing clinical recovery monitoring are expanding recurring testing volumes, supporting long-term service utilization through routine surveillance rather than one-time screening alone.

Which drug segment dominates the drug of abuse testing services market?

Cannabis/Marijuana led the market with a 60.17% share in 2026, supported by its frequent inclusion in workplace screening programs, compliance testing panels, and routine toxicology workflows.

Why is Cannabis/Marijuana the fastest-growing segment in the market?

Cannabis/Marijuana continues to grow fastest because testing demand remains consistently high, with service providers seeing strong utilization as it remains a core component of standard screening menus.

Why does North America lead the drug of abuse testing services market?

North America holds 53.66% share due to established testing infrastructure, widespread workplace screening programs, and strong demand from healthcare, justice, and regulated industries.

What is driving growth in Asia Pacific for drug of abuse testing services?

Asia Pacific growth at 5.7% CAGR is driven by expanding workplace screening adoption, rising substance monitoring awareness, and improving access to structured testing services.

Which companies dominate the drug of abuse testing services landscape?

Key companies in the drug of abuse testing services market include Quest Diagnostics Incorporated (United States), Abbott Laboratories (United States), Laboratory Corporation of America Holdings (United States), Clinical Reference Laboratory, Inc. (United States), Cordant Health Solutions (United States), Legacy Medical Services (United States), DrugScan, Inc. (United States), Omega Laboratories, Inc. (United States), Psychemedics Corporation (United States), Millennium Health, LLC (United States).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →